Virginia Tech Opioid Vaccine Breakthrough | AcademicJobs
Virginia Tech researchers advance hybrid nanoparticle opioid vaccine, blocking oxycodone and fentanyl to combat US crisis.
public-healthresearch-publication-newsbiomedical-engineering
No reviews yet. Be the first to rate Marion!
Virginia Tech researchers advance hybrid nanoparticle opioid vaccine, blocking oxycodone and fentanyl to combat US crisis.